Must we compare the preventive approach of cardiovascular risk in type 2 diabetes mellitus to secondary prevention? (II);¿Debe equipararse el abordaje preventivo del riesgo cardiovascular en la diabetes mellitus tipo 2 a la prevención secundaria? (II)

FMC Formacion Medica Continuada en Atencion Primaria

Volumn 12, Issue 4, 2005, Pages 236-245

  Millaruelo Trillo, J M ^a  

^a Centro de Salud Torrero La Paz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947578987     PISSN: 11342072     EISSN: 15789675     Source Type: Journal    
DOI: 10.1016/S1134-2072(05)75193-8     Document Type: Article

References (109)

1. E. Barret-Connor, B. Cohn, D. Wingard, and S. Edelstein Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? JAMA 265 1991 627 631
2. E. Barret-Connor, and A. Ferrara Isolated postchallenge hyperglycemia and the risk of fatal cvd in older women and men. The Rancho Bernardo Study Diabetes Care 21 1998 1236 1239 (Pubitemid 28365676)
3. M. Wei, S. Gaskill, S. Haffner, and M. Stern Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality Diabetes Care 21 1998 1167 1172
4. W. Kannel, and P. Wilson Risk factors that attenuate the female coronary disease advantage Arch Intern Med 155 1995 57 61
5. K. Mak, and S. Haffner Diabetes abolishes the gender gap in coronary heart disease Eur Heart J 24 2003 1385 1386 (Pubitemid 36961828)
6. W. Lee, A. Cheang, D. Cape, and B. Zinman Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies Diabetes Care 23 2000 962 968 (Pubitemid 30480024)
7. A. Kanaya, D. Grady, and E. Barret-Connor Metaanalisis explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes Arch Intern Med 162 2002 1737 1745
8. S. Natarajan, Y. Liao, G. Cao, S. Lipsitz, and D. McGee Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease Arch Intern Med 163 2003 1735 1740 (Pubitemid 36898963)
9. B. Howard, L. Cowan, O. Go, T. Welty, D. Robbins, and E. Lee Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study Diabetes Care 21 1998 1258 1264 (Pubitemid 28365680)
10. The DECODE Study Group Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes Diabetologia 46 2003 608 617
11. T. Orchard The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus Ann Med 28 1996 323 333 (Pubitemid 26268251)
12. J. Sowers Diabetes mellitus and cardiovascular disease in women Arch Intern Med 158 1998 617 621 (Pubitemid 28144819)
13. E. Barret-Connor, E. Giardina, A. Gitt, U. Gudat, and H. Steimberg Women and heart disease Arch Intern Med 164 2004 934 942
14. D. Singh Impact of gender on diabetes mellitus and its associated risk factors J Gen Specif Med 4 2001 28 36 (Pubitemid 34023972)
15. Center for Disease Control and Prevention (CDC) [citado 11 oct 2004]. Disponible en: http://www.cdc.gov/health/diabetes.htm
16. B. Campaigne, and K. Wishner Gender-specific health care in diabetes mellitus J Gen Specif Med 3 2000 51 58
17. [Citado 11 oct 2004]. Disponible en: http://www.elpais.es/buscadores/ articulo/20040916elpepisoc
18. Z. Bloomgarden Type 2 diabetes in the young: the evolving epidemy Diabetes Care 27 2004 998 1010 (Pubitemid 38420231)
19. T. Hillier, and K. Pedula Complications in young adults with early-onset type 2 diabetes Diabetes Care 26 2003 2999 3005
20. Risk Engine UKPDS [citado 11 Oct 2004]. Disponible en: http://www.dtu.ox.ac.uk/index.html?maindoc=/riskengine/
21. E. Cho, E.B. Rimm, M.J. Stampfer, W.C. Willett, and F.B. Hu The impact of diabetes mellitus and prior yocardial infarction on mortality from all causes and from coronary heart disease in men J Am Coll Cardiol 40 2002 954 960
22. F.B. Hu, M.J. Stampfer, C.G. Solomon, S. Liu, W.C. Willett, and F.E. Speizer The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years follow-up Arch Intern Med 161 2001 1717 1723 (Pubitemid 32679546)
23. C. Fox, L. Sullivan, R. D'Agostino, and P. Wilson The significant effect of diabetes duration on coronary heart disease mortality. The Framingham Heart Study Diabetes Care 2004 704 708 (Pubitemid 38280537)
24. C. Morgan, C. Currie, N. Stott, M. Smithers, C. Butler, and J. Peters The prevalence of multiple diabetes-related complications Diabet Med 17 2000 146 151 (Pubitemid 30159051)
25. E. Brun, R. Nelson, P. Bennett, G. Imperatore, G. Zoppini, and G. Verlato Diabetes duration and cause-specific mortality in the Verona Diabetes Study Diabetes Care 23 2000 1119 1123 (Pubitemid 30616799)
26. B. Issa, and F. Hanna Insulin resistance, the metabolic syndrome and risk of cardiovascular disease: a complex story Curr Opin Lipidol 14 2003 405 407 (Pubitemid 36951909)
27. B. Costa, J. Cabre, and F. Martin Síndrome metabólico, resistencia a la insulina y diabetes. ¿Qué se oculta bajo la punta del iceberg? Aten Primaria 31 2003 436 445 (Pubitemid 36966101)
28. J. Ninomiya, G. L'Ítalien, and M. Criqui Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey Circulation 109 2003 42 46
29. P.M. Ridker, J.E. Buring, N.R. Cook, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women Circulation 107 2003 391 397
30. N. Sattar, A. Gaw, and O. Scherbakova Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study Circulation 108 2003 414 419 (Pubitemid 36935533)
31. P. Deedwania Metabolic syndrome and vascular disease is nature or nurture leading the new epidemic of cardiovascular disease Circulation 109 2004 2 4 (Pubitemid 38056010)
32. C. Balllantyne, A. Olson, T. Cook, M. Mercuri, T. Pedersen, and J. Kjekskus Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S Circulation 104 2001 3046 3051 (Pubitemid 34014055)
33. B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lathi, and M. Nissen Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 2001 683 689 (Pubitemid 32893993)
34. H. Lakka, D. Laaksonen, T. Lakka, L. Niskanen, E. Kumpusalo, and J. Tuomilehto The metabolic syndrome and total and CVD mortality in men JAMA 288 2002 2709 2716
35. G. Hu, Q. Qiao, J. Tuomilehto, B. Balkau, K. Johnsen, and K. Pyorala Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in Nondiabetic European men and women Arch Intern Med 164 2004 1066 1076 (Pubitemid 38668985)
36. C.h. Alexander, P. Landsman, S. Teutch, and S. Haffner NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older Diabetes 52 2003 1210 1214 (Pubitemid 36523358)
37. B. Isomaa, M. Henricsson, P. Almgren, T. Tuomi, and M. Taskinen The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes Diabetologia 44 2001 1148 1154 (Pubitemid 32842461)
38. J. Gimeno, L. Lou, E. Molinero, B. Poned, and D. Portilla Influencia del síndrome metabólico en el riesgo cardiovascular de pacientes con diabetes tipo 2 Rev Esp Cardiol 57 2004 507 513 (Pubitemid 38997108)
39. C. Alebiosu, and O. Odusan Metabolic syndrome in subjects with type-2 diabetes mellitus J National Med Assoc 96 2004 817 821 (Pubitemid 38745790)
40. C. Lydakis, and G. Lip Microalbuminuria and cardiovascular risk QJM 91 1998 381 391 (Pubitemid 28286837)
41. G. Diercs, A. Van Boven, J. Hillege, P. de Jong, J. Rouleau, and W. Van Gilst The importance of microalbuminuria as a cardiovascular risk indicator: a review Can J Cardiol 18 2002 525 535
42. R. Donelly, J. Yeung, and G. Manning Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes J Hypertens Supl 1 2003 7 12
43. M. Yuyun, K. Khaw, R. Luben, A. Welch, S. Bingham, and N. Day Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) Int J Epidemiol 33 2004 189 198 (Pubitemid 38500176)
44. J. Gimeno, B. Poned, L. Lou, and F. Castro Microalbuminuria and clinical proteinuria as the main predictive factors of cardiovascular morbidity and mortality in patients with type 2 diabetes Rev Clin Esp 203 2003 526 531
45. G. Stripoli, M. Craig, J. Deeks, F. Schena, and J. Craig Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review BMJ 329 2004 828 839 (Pubitemid 39388408)
46. F. Hu, M. Stampfer, S. Haffner, C. Solomon, W. Willet, and J. Manson Elevated risk of cardiovascular disease prior to clinical diagnosis of type II diabetes Diabetes Care 25 2002 1129 1134 (Pubitemid 41071162)
47. S. Haffner, P. Stern, P. Hazuda, D. Mitchell, and K. Patterson Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263 1990 2893 2898
48. P. Parikka, J. Erikson, J. Lindstrom, M. Laakso, A. Louhreanta, and M. Mennelin Prevalence of the metabolic syndrome and its components findings from a Finnish general population sample and the Diabetes Prevention Study cohort Diabetes Care 27 2004 2135 2140 (Pubitemid 39167175)
49. A. Norhamar, A. Tenerz, G. Nilsson, A. Hamsten, S. Efendic, and L. Ryden Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study Lancet 359 2002 2140 2144 (Pubitemid 34694020)
50. I. Stransers, R. Van Gelder, H. Spruijt, J. Twisk, and R. Heine Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus Arch Intern Med 164 2004 982 988 (Pubitemid 38581518)
51. J. Sala, F. Masia, J. González de Molina, D. Bosh, M. Gil, and J. Marrugat Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission J Epidemiol Community Health 56 2002 707 712
52. K. Franklin, R. Goldberg, F. Spencer, W. Klein, A. Budal, and D. Brieger Implications of diabetes in patients with acute coronary syndromes Arch Intern Med 164 2004 1457 1463
53. B. Balkau, X. Jouven, P. Ducimetiere, and E. Eschwege Diabetes as a risk factor for sudden death Lancet 354 1999 1968 1969
54. J. Tedesco, R. Scott, B. Williams, S. Kopecky, D. Dvorak, and G. Reeder Effect of diabetes on the mortality risk of cardiogenic shock in a community- based population Mayo Clin Proc 78 2003 561 566 (Pubitemid 36529896)
55. K. Malmberg, L. Ryden, A. Hamstem, J. Herlitz, A. Waldenröm, H. Wedel Of the DIGAMI Study group Effects of insulin treatment on causespecific one year mortality and morbidity in diabetic patients with acute myocardial infarction Eur Heart J 17 1996 1337 1344 (Pubitemid 26306661)
56. R. Marfella, M. Sicusclachi, K. Esposito, A. Sellitto, V. De Fanis, and C. Romano Effects of stress hyperglycemia on acute myocardial infarction Diabetes Care 26 2003 3129 3135
57. S. Miettinen, S. Lehto, V. Salomaa, M. Mahonen, and M. Niemela Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group Diabetes Care 21 1998 69 75
58. P. Donnan, D. Boyle, J. Broomhall, K. Hunter, R. Newton, and A. Morris Prognosis following first acute myocardial infarction in type 2 diabetes: a comparative population study Diabet Med 19 2002 448 455 (Pubitemid 34639154)
59. K. Malmberg, S. Yusuf, H. Gerstein, J. Brown, F. Zhao, and D. Hunt Impact of diabetes on longterm prognosis in patients with unstable angina and nonQ-wave myocardial infarction Circulation 102 2000 1014 1019
60. C. Muller, F. Neumann, M. Ferenc, A. Perruchoud, and H. Buttner Impact of diabetes mellitus on long-term outcome after unstable angina and non-ST-segment elevation myocardial infarction treated with a very early invasive strategy Diabetologia 47 2004 1188 1195 (Pubitemid 39093315)
61. A. Abizaid, R. Kornowski, G. Mintz, M. Hong, S. Abizaid, and R. Mehran The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation J Am Coll Cardiol 32 1998 584 589 (Pubitemid 28435240)
62. J. Gilbert, J. Raboud, and B. Zinman Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting Diabetes Care 27 2004 990 994 (Pubitemid 38420228)
63. D. Hasdai, C. Granger, S. Srivatsa, D. Criger, S. Ellis, and R. Califf Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb angioplasty substudy J Am Coll Cardiol 35 2000 1502 1512 (Pubitemid 30307493)
64. W. Laskey, F. Selzer, H. Vlachos, J. Johnston, A. Jacobs, and S. King Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus Am J Cardiol 90 2002 1062 1067
65. R. Lorusso, S. Pentiricci, R. Raddino, T. Scarabelli, C. Zambelli, and V. Villanacci Undergoing percutaneous catheter intervention. Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits Am J Cardiol 20 2002 1062 1067
66. L. Silva, and J. Ortigosa Revascularizacion en pacientes diabéticos Cardiovascular risk factors 11 2002 394 401
67. J. González Santos, and M. Castaño Cirugía de revascularización coronaria en el paciente diabético Rev Esp Cardiol 55 2002 1311 1322
68. A. Zamora, and J. Marrugat Pronóstico de los pacientes diabéticos con cardiopatía isquémica Rev Esp Cardiol 55 2002 751 762
69. B. Healy The Yentl syndrome N Engl J Med 325 1991 274 276
70. B. Jannand, B. Savin, G. Habib, M. Bory, P. Vague, and V. Lassmann Silent myocardial ischemia in patients with diabetes: who to screen Diabetes Care 22 1999 1396 1400 (Pubitemid 29418229)
71. R. Nesto Screening for asymptomatic coronary artery disease in diabetes Diabetes Care 22 1999 1393 1394 (Pubitemid 29350900)
72. F. Wackers, L. Young, S. Inzucchi, D. Chyun, J. Davey, and E. Barret Detection of silent myocardial ischemia in asymptomatic diabetic subjects. The DIAD study Diabetes Care 27 2004 1954 1961 (Pubitemid 38989238)
73. L. Kuller, P. Velentgas, J. Barzilay, N. Beauchamp, D. O'Leary, and P. Savage Diabetes mellitus subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality Arterioscler Thromb Vasc Biol 20 2000 823 829 (Pubitemid 30151699)
74. R. Tabibiazar, and S. Edelman Silent ischemia in people with diabetes: a condition that must be heard Clinical Diabetes 21 2003 5 9
75. T. Davis, C. Cull, and R. Holman Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes. UK Prospective Diabetes Study (UKPDS 55) Diabetes Care 24 2001 1167 1174 (Pubitemid 33716393)
76. UK Prospective Diabetes Study Group Ethnicity and cardiovascular disease. The incidence of myocardial infarction in white, South Asian, and Afro-Caribbean patients with type 2 diabetes (UK Prospective Diabetes Study 32) Diabetes Care 21 1998 1271 1277
77. N. Abate, and M. Chandalia The impact of ethnicity on type 2 diabetes J Diabetes Complications 37 2000 39 58 (Pubitemid 36042792)
78. D. Bonds, D. Zaccaro, A. Karter, J. Selby, M. Saad, and D. Goff Ethnic and racial differences in diabetes care. The Insulin Resistance Atherosclerosis Study Diabetes Care 26 2003 1040 1046 (Pubitemid 36929245)
79. M. Harris Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes Diabetes Care 24 2001 434 439
80. J. Fitzgerald, L. Gruppen, R. Anderson, M. Funnell, S. Jacober, and G. Grunberger The influence of treatment modality and ethnicity on attitudes in type 2 diabetes Diabetes Care 23 2000 313 318 (Pubitemid 30131736)
81. F. Capuccio, P. Oakeshott, P. Strazzullo, and S. Kerry Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study BMJ 325 2002 1271 1276 (Pubitemid 35430582)
82. N. Chatuverdy, J. Jarret, M. Shipley, and J. Fuller Socioeconomic gradient in morbidity and mortality in people with diabetes: cohort study findings from the Whitehall study and the WHO multinational study of vascular disease in diabetes BMJ 316 1998 100 106 (Pubitemid 28121106)
83. C. Weng, D. Coppini, and P. Sonksen Geografic and social factors are related to increased morbidity and mortality rates in diabetic patients Diabet Med 17 2000 612 617
84. H. Keen Diabetes in Europe ± psychosocial risk factors? Diabet Med 18 2001 1 2 (Pubitemid 32158100)
85. J. Fisher The crucial link between literacy and health Ann Intern Med 139 2003 875 878
86. B. Vastag Low health literacy called a major problem JAMA 291 2004 2181 2182 (Pubitemid 38608163)
87. M. Williams, D. Baker, R. Parker, and J. Nurss Relationship of functional health literacy to patients' knowledge of their chronic disease Arch Intern Med 158 1998 166 172
88. D. Schillinger, K. Grumbach, J. Piette, F. Wang, D. Osmond, and C. Daher Association of health literacy with diabetes outcomes JAMA 288 2002 475 482
89. D. Schillinger, J. Piette, K. Grumbach, F. Wang, C. Wilson, and C. Daher Closing de loop. Physician communication with diabetic patients who have low health literacy Arch Intern Med 163 2003 83 90 (Pubitemid 36091605)
90. V. Fonseca, S. Desouza, S. Asnani, and I. Jialal Nontraditional risk factors fpr cardiovascular disease in diabetes Endocrine Rev 25 2004 153 175 (Pubitemid 38269978)
91. J. Hayden, and P. Reaven Cardiovascular disease in diabtes mellitus type 2: a potential role for novel cardiovascular risk factors Curr Opin Lipidol 11 2000 519 528
92. I. Saito, A. Folsom, F. Brancati, B. Duncan, L. Chambless, and P. McGovern Nontraditional risk factors for coronary heart disease incidence among persons with diabetes Ann Intern Med 133 2000 81 91
93. H. Vlassara The AGE-receptor in the pathogenesis of diabetic complications Diabetes Metab Res Rev 17 2001 436 443 (Pubitemid 34030746)
94. S. Yusuf, S. Reddy, S. Ounpuu, and S. Anand Global burden of cardiovascular diseases (II): variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies Circulation 104 2001 2855 2864 (Pubitemid 33126663)
95. N. Morrish, S. Wang, L. Stevens, J. Fuller, and H. Keen Mortality and causes of death in the WHO multinational study of vascular disease in diabetes Diabetologia 44 Supl 2 2001 14 21
96. T. Matsumoto, Y. Ohashi, N. Yamada, and M. Kikuchi Coronary heart disease mortality is actually low in diabetic Japanese by direct comparison with the Joslin cohort Diabetes Care 17 1994 1062 1063 (Pubitemid 24268622)
97. M. Laakso, T. Ronemaa, S. Lehto, P. Puuka, V. Kallio, and K. Pyorala Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations? Diabetologia 38 1995 487 493
98. The DAI Study Group The prevalence of coronary heart disease in type 2 diabetic patients in Italy: the DAI study Diabet Med 21 2004 738 745
99. J. Arteagoitia, M. Larrañaga, J. Rodríguez, I. Fernández, and J. Piniés Incidence, prevalence and coronary heart disease risk level in known type 2 diabetes Diabetologia 46 2003 899 909
100. F. Rius, I. Salinas, A. Lucas, R. Romero, and A. Sanmartin A prospective study of cardiovascular disease in patients with type 2 diabetes 6.3 years of follow-up J Diabetes Complications 17 2003 235 242 (Pubitemid 37040768)
101. E. Damsgaard, A. Frøland, O. Jørgensen, and C. Mogensen Eight to nine year mortality in known non-insulin dependent diabetics and controls Kidney Int 41 1992 731 735
102. M. Mattock, N. Morrish, G. Viberti, H. Keen, A. Fitzgerald, and G. Jackson Prospective study of microalbuminuria as predictor of mortality in NIDDM Diabetes 41 1992 736 741
103. M. Uusitupa, L. Niskanen, O. Siitonen, E. Voutllainen, and K. Pyorala Tenyear cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulindependent) diabetic and non-diabetic subjects Diabetologia 36 1993 1175 1184
104. J. Kuusisto, L. Mykkaanen, K. Pyorala, and M. Laakso NIDDM and its metabolic control predict coronary heart disease in elderly subjects Diabetes 43 1994 960 967 (Pubitemid 24230698)
105. M. Hanefeld, S. Fischer, U. Julius, J. Schulze, U. Schwanebeck, and H. Schmechel Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up Diabetologia 39 1996 1577 1583 (Pubitemid 26397370)
106. J. Meigs, D. Singer, L. Sullivan, K. Dukes, R. D'Agostino, and D. Nathan Metabolic control and prevalent cardiovascular disease in non-insulindependent diabetes mellitus (NIDDM) Am J Med 102 1997 38 47
107. M. Mattock, D. Barnes, G. Viberti, H. Keen, D. Burt, and J. Hughes Microalbuminuria and coronary heart disease in NIDDM. An incidence study Diabetes 47 1998 1786 1792 (Pubitemid 28476254)
108. C. Morgan, C. Currie, N. Stott, M. Smithers, C. Butler, and J. Peters The prevalence of multiple diabetes-related complications Diabet Med 17 2000 146 151 (Pubitemid 30159051)
109. A. Grimaldi, V. Grange, H. Allannic, P. Passa, M. Rodier, and P. Cornet Epidemiological analisis of patients with type 2 diabetes in France J Diabetes Complications 14 2000 242 249